Table 3.
Comparison between pre- and post-treatment visual field index slopes in each group.
| MD Slopes (dB/Month) | p Value | VFI Slopes (%/Month) | p Value | |||
|---|---|---|---|---|---|---|
| Pretreatment | Post-Treatment | Pretreatment | Post-Treatment | |||
| Global (mean ± SD) |
−0.0613 ± 0.1736 | 0.0867 ± 0.3092 | 0.005 | −0.1107 ± 0.2781 | 0.1625 ± 0.8499 | 0.018 |
| Vitamin C (mean ± SD) |
−0.0502 ± 0.1459 | 0.055 ± 0.2895 | 0.350 | −0.079 ± 0.3665 | 0.1425 ± 0.8992 | 0.485 |
| DHA (mean ± SD) |
−0.0135 ± 0.1116 | 0.0295 ± 0.1939 | 0.733 | −0.0509 ± 0.1998 | 0.0150 ± 0.5971 | 0.532 |
| Citicoline (mean ± SD) |
−0.0624 ± 0.1307 | 0.1029 ± 0.4504 | 0.192 | −0.1364 ± 0.3151 | 0.1733 ± 1.2439 | 0.371 |
| DHA + Citicoline (mean ± SD) |
−0.1041 ± 0.2471 | 0.1383 ± 0.2544 | 0.006 | −0.1557 ± 0.2310 | 0.2780 ± 0.5661 | 0.006 |
MD, mean defect of visual field; dB, decibels; VFI, visual field index; SD, standard deviation; DHA, docosahexaenoic acid.